Tiziana Life Sciences TLSA
NASDAQ TLSA
$0.96 -0.01 (-1.30%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tiziana Life Sciences (TLSA) Non-Current Assets (2017 - 2025)

Tiziana Life Sciences (TLSA) posted Non-Current Assets of $2.9 million for Q4 2025, up 16250.0% on a QoQ basis from $18000.0 in Q2 2025, and up 18293.75% year-over-year from N/an in Q4 2024.

Analysis

Tiziana Life Sciences (TLSA) Non-Current Assets (2017 - 2025) Analysis & Trends

Tiziana Life Sciences has reported Non-Current Assets for 9 years, with the latest figure at $2.9 million in Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 18293.75% year-over-year to $2.9 million in Q4 2025; TTM through Dec 2025 was $12.2 million, a 76287.5% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 18293.75% from the prior year.
  • Non-Current Assets was $2.9 million for Q4 2025 at Tiziana Life Sciences, up from $18000.0 in the prior quarter.
  • The five-year high for Non-Current Assets was $4.8 million in Q4 2023, with the low at $16000.0 in Q2 2024.
  • Average Non-Current Assets over 5 years is $1.6 million, with a median of $1.5 million recorded in 2021.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets tumbled 99.67% in 2024, then surged 18293.75% in 2025.
  • Over 5 years, Non-Current Assets stood at $147000.0 in 2021, then jumped by 1393.2% to $2.2 million in 2022, then jumped by 120.82% to $4.8 million in 2023, then sank by 99.67% to $16000.0 in 2024, then soared by 18293.75% to $2.9 million in 2025.
  • The last three Non-Current Assets figures came in at $2.9 million (Q4 2025), $18000.0 (Q2 2025), and $16000.0 (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 564.41 Mn
10 Tiziana Life Sciences 113.92 Mn 113.92 Mn - 2.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.94 Mn
Jun 30, 2025 18,000.00
Dec 31, 2024 16,000.00
Jun 30, 2024 16,000.00
Dec 31, 2023 4.85 Mn
Jun 30, 2023 2.24 Mn
Dec 31, 2022 2.20 Mn
Jun 30, 2022 2.81 Mn
Dec 31, 2021 147,000.00
Jun 30, 2021 715,000.00
Dec 31, 2020 480,000.00
Jun 30, 2020 951,138.83
Dec 31, 2019 853,721.34
Jun 30, 2019 746,061.32
Dec 31, 2018 286,949.09
Jun 30, 2018 311,979.26
Dec 31, 2017 23,897.97